Immuneering Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Immuneering Corporation (IMRX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $4.26 per share as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-05
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.26.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.33.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.42.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.49.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $4.26 10-Q · filed 2026-08-05 |
| 2026-03-31 | $4.33 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.42 10-K · filed 2026-03-06 |
| 2025-09-30 | $4.49 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.60 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.69 10-Q · filed 2025-05-05 |
| 2024-12-31 | $4.79 10-K · filed 2025-03-20 |
| 2024-09-30 | $4.88 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.93 10-Q · filed 2024-08-06 |
| 2024-03-31 | $6.39 10-Q · filed 2024-05-07 |
| 2023-12-31 | $5.99 10-K · filed 2024-03-01 |
| 2023-09-30 | $5.81 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.70 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.63 10-Q · filed 2023-05-04 |
| 2022-12-31 | $5.35 10-K · filed 2023-03-06 |
| 2022-09-30 | $5.17 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.59 10-Q · filed 2022-08-10 |
| 2022-03-31 | $3.24 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.01 10-K · filed 2022-03-10 |
| 2021-09-30 | $3.01 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.01 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |